Global Health, 543654, MEDANTA Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28,982.98
59.37
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

28,302.00
N/A
9.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.61
16.90
14.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.90
33.38
12.05

PAT CAGR (%)

10 Years
5 Years
3 Years

12.51
67.42
34.58

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 664.61 586.02 13.41% 611.45 550.51 11.07% 578.64 506.16 14.32% 561.68 489.79 14.68%
Expenses 514.30 451.84 13.82% 479.15 435.24 10.09% 456.43 400.08 14.08% 439.15 394.31 11.37%
EBITDA 150.31 134.17 12.03% 132.30 115.26 14.78% 122.22 106.07 15.23% 122.53 95.48 28.33%
EBIDTM 22.62% 22.90% 21.64% 20.94% 21.12% 20.96% 21.81% 19.49%
Other Income 23.58 20.37 15.76% 26.70 27.28 -2.13% 32.55 24.85 30.99% 25.83 12.52 106.31%
Interest 5.37 6.11 -12.11% 5.95 6.38 -6.74% 6.21 6.38 -2.66% 5.76 6.49 -11.25%
Depreciation 24.91 21.54 15.65% 23.30 20.43 14.05% 23.39 20.35 14.94% 21.73 21.62 0.51%
PBT 143.61 126.89 13.18% 129.74 115.74 12.10% 125.17 104.19 20.14% 120.87 79.89 51.30%
Tax 39.14 31.80 23.08% 33.46 29.53 13.31% 32.93 23.24 41.70% 33.53 21.12 58.76%
PAT 104.47 95.09 9.86% 96.28 86.21 11.68% 92.24 80.95 13.95% 87.34 58.77 48.61%
PATM 15.72% 16.23% 15.75% 15.66% 15.94% 15.99% 15.55% 12.00%
EPS 3.89 3.54 9.89% 3.59 3.21 11.84% 3.44 3.02 13.91% 3.25 2.19 48.40%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 956.55 850.45 12.48% 861.08 779.58 10.45% 808.63 707.06 14.37% 832.60 694.32 19.92%
Expenses 728.27 631.09 15.40% 674.75 595.16 13.37% 629.28 540.32 16.46% 620.51 534.35 16.12%
EBITDA 228.29 219.36 4.07% 186.32 184.42 1.03% 179.35 166.74 7.56% 212.09 159.97 32.58%
EBIDTM 23.87% 25.79% 21.64% 23.66% 22.18% 23.58% 25.47% 23.04%
Other Income 18.22 14.24 27.95% 21.93 14.92 46.98% 27.42 24.77 10.70% 21.93 11.90 84.29%
Interest 15.97 20.09 -20.51% 17.98 17.92 0.33% 18.23 20.48 -10.99% 17.68 20.67 -14.47%
Depreciation 49.43 42.91 15.19% 46.62 40.38 15.45% 45.45 37.95 19.76% 43.98 38.75 13.50%
PBT 181.10 170.60 6.15% 143.65 141.04 1.85% 143.09 133.08 7.52% 172.36 112.45 53.28%
Tax 50.28 45.44 10.65% 37.39 39.03 -4.20% 15.74 32.01 -50.83% 48.82 31.84 53.33%
PAT 130.82 125.16 4.52% 106.26 102.01 4.17% 127.35 101.07 26.00% 123.54 80.61 53.26%
PATM 13.68% 14.72% 12.34% 13.09% 15.75% 14.29% 14.84% 11.61%
EPS 4.87 4.66 4.51% 3.96 3.80 4.21% 4.74 3.77 25.73% 4.61 3.01 53.16%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 2,416.38 2,280.01 1,973.54 1,764.96 1,227.40 1,472.09 1,381.89 1,194.04 1,069.69 916.74 743.89 Net Sales Growth 13.31% 15.53% 11.82% 43.80% -16.62% 6.53% 15.73% 11.62% 16.68% 23.24% Cost Of Goods Sold 595.50 540.33 458.70 441.02 297.77 319.20 363.06 321.95 0.00 0.00 0.00 Gross Profit 1,820.88 1,739.67 1,514.83 1,323.94 929.63 1,152.88 1,018.84 872.09 1,069.69 916.74 743.89 GP Margin 75.36% 76.30% 76.76% 75.01% 75.74% 78.32% 73.73% 73.04% 100% 100% 100% Total Expenditure 1,889.03 1,776.65 1,551.52 1,384.17 1,054.48 1,253.59 1,076.91 930.86 851.47 743.81 573.20 Power & Fuel Cost - 35.86 36.84 31.80 27.43 31.11 29.22 26.68 0.00 0.00 0.00 % Of Sales - 1.57% 1.87% 1.80% 2.23% 2.11% 2.11% 2.23% 0% 0% 0% Employee Cost - 591.06 532.91 494.66 415.91 522.30 471.70 421.56 0.00 0.00 0.00 % Of Sales - 25.92% 27.00% 28.03% 33.89% 35.48% 34.13% 35.31% 0% 0% 0% Manufacturing Exp. - 346.11 305.30 261.87 178.72 133.30 25.75 22.98 0.00 0.00 0.00 % Of Sales - 15.18% 15.47% 14.84% 14.56% 9.06% 1.86% 1.92% 0% 0% 0% General & Admin Exp. - 227.35 202.27 143.99 119.08 231.18 96.56 72.81 851.47 743.81 573.20 % Of Sales - 9.97% 10.25% 8.16% 9.70% 15.70% 6.99% 6.10% 79.60% 81.14% 77.05% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 35.93 15.49 10.83 15.59 16.50 90.61 64.88 0.00 0.00 0.00 % Of Sales - 1.58% 0.78% 0.61% 1.27% 1.12% 6.56% 5.43% 0% 0% 0% EBITDA 527.36 503.36 422.02 380.79 172.92 218.50 304.98 263.18 218.22 172.93 170.69 EBITDA Margin 21.82% 22.08% 21.38% 21.57% 14.09% 14.84% 22.07% 22.04% 20.40% 18.86% 22.95% Other Income 108.66 102.87 47.59 35.04 28.35 43.54 45.40 36.33 33.51 25.33 15.12 Interest 23.29 30.46 31.82 32.83 29.20 32.54 14.29 8.92 0.00 0.00 56.14 Depreciation 93.33 87.09 86.09 87.17 87.64 98.57 68.53 61.74 46.77 45.63 43.57 PBT 519.39 488.67 351.71 295.83 84.42 130.93 267.57 228.86 204.96 152.63 86.10 Tax 139.06 127.78 88.46 77.04 27.14 28.18 91.93 79.35 71.59 49.49 5.83 Tax Rate 26.77% 26.15% 25.15% 26.04% 32.15% 21.52% 34.36% 34.67% 34.93% 32.42% 6.77% PAT 380.33 360.89 263.25 218.78 57.28 102.76 175.63 149.51 133.37 103.14 80.28 PAT before Minority Interest 380.33 360.89 263.25 218.78 57.28 102.76 175.63 149.51 133.37 103.14 80.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.74% 15.83% 13.34% 12.40% 4.67% 6.98% 12.71% 12.52% 12.47% 11.25% 10.79% PAT Growth 18.48% 37.09% 20.33% 281.95% -44.26% -41.49% 17.47% 12.10% 29.31% 28.48% EPS 14.16 13.44 9.80 8.15 2.13 3.83 6.54 5.57 4.97 3.84 2.99

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 16 Mar 15
Net Sales 3,458.86 3,275.11 2,709.88 2,167.30 1,446.74 1,500.42 1,382.05 1,194.25 Net Sales Growth 14.10% 20.86% 25.03% 49.81% -3.58% 8.56% 15.73% Cost Of Goods Sold 821.25 747.96 615.24 532.97 343.66 324.83 363.07 321.97 Gross Profit 2,637.61 2,527.16 2,094.63 1,634.32 1,103.09 1,175.59 1,018.98 872.28 GP Margin 76.26% 77.16% 77.30% 75.41% 76.25% 78.35% 73.73% 73.04% Total Expenditure 2,652.81 2,466.17 2,073.63 1,709.22 1,249.84 1,308.78 1,080.57 931.57 Power & Fuel Cost - 59.91 57.12 47.06 38.56 34.60 29.22 26.68 % Of Sales - 1.83% 2.11% 2.17% 2.67% 2.31% 2.11% 2.23% Employee Cost - 734.86 635.65 567.96 466.34 538.78 471.87 422.13 % Of Sales - 22.44% 23.46% 26.21% 32.23% 35.91% 34.14% 35.35% Manufacturing Exp. - 513.30 422.07 361.45 231.24 139.21 29.97 19.90 % Of Sales - 15.67% 15.58% 16.68% 15.98% 9.28% 2.17% 1.67% General & Admin Exp. - 301.31 266.49 185.54 146.23 252.56 101.94 74.75 % Of Sales - 9.20% 9.83% 8.56% 10.11% 16.83% 7.38% 6.26% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 108.84 77.06 14.24 23.82 18.80 84.50 66.14 % Of Sales - 3.32% 2.84% 0.66% 1.65% 1.25% 6.11% 5.54% EBITDA 806.05 808.94 636.25 458.08 196.90 191.64 301.48 262.68 EBITDA Margin 23.30% 24.70% 23.48% 21.14% 13.61% 12.77% 21.81% 22.00% Other Income 89.50 74.66 49.29 38.52 31.41 43.84 45.34 35.85 Interest 69.86 83.78 86.33 86.32 72.64 56.56 14.30 8.92 Depreciation 185.48 172.73 149.91 129.71 123.21 115.04 70.38 63.67 PBT 640.20 627.10 449.29 280.56 32.47 63.89 262.14 225.95 Tax 152.23 149.04 123.21 84.36 3.66 27.54 91.93 79.30 Tax Rate 23.78% 23.77% 27.42% 30.07% 11.27% 43.11% 35.07% 35.10% PAT 487.97 478.19 326.08 196.20 28.81 36.35 170.23 147.18 PAT before Minority Interest 488.15 478.06 326.08 196.20 28.81 36.35 170.21 146.65 Minority Interest 0.18 0.13 0.00 0.00 0.00 0.00 0.02 0.53 PAT Margin 14.11% 14.60% 12.03% 9.05% 1.99% 2.42% 12.32% 12.32% PAT Growth 19.35% 46.65% 66.20% 581.01% -20.74% -78.65% 15.66% EPS 18.17 17.81 12.14 7.31 1.07 1.35 6.34 5.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 2,848.80 2,488.86 1,739.75 1,483.63 1,422.72 Share Capital 53.70 53.64 50.64 82.09 81.84 Total Reserves 2,790.71 2,430.09 1,683.59 1,369.22 1,292.44 Non-Current Liabilities 958.08 868.88 811.89 666.27 324.45 Secured Loans 0.00 33.31 66.45 0.48 18.08 Unsecured Loans 0.00 24.67 22.27 18.87 0.00 Long Term Provisions 792.15 650.92 552.22 458.68 84.99 Current Liabilities 419.59 396.64 301.92 268.20 260.45 Trade Payables 137.80 142.33 103.28 109.21 118.04 Other Current Liabilities 251.45 234.32 185.07 136.93 126.89 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 30.34 19.99 13.58 22.06 15.53 Total Liabilities 4,226.47 3,754.38 2,853.56 2,418.10 2,007.62 Net Block 841.21 809.89 826.95 851.40 928.87 Gross Block 1,580.95 1,472.48 1,409.64 1,353.68 1,350.14 Accumulated Depreciation 739.74 662.59 582.69 502.27 421.27 Non Current Assets 2,935.91 2,356.47 2,137.46 1,962.82 1,571.85 Capital Work in Progress 184.09 74.94 6.42 4.16 3.47 Non Current Investment 790.10 764.99 734.02 625.55 500.50 Long Term Loans & Adv. 1,109.32 680.41 562.48 470.38 121.60 Other Non Current Assets 11.20 26.24 7.59 11.32 17.41 Current Assets 1,290.55 1,397.92 716.12 455.29 435.77 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 44.27 42.21 40.02 31.69 32.26 Sundry Debtors 191.87 173.09 173.05 129.84 148.42 Cash & Bank 959.21 1,144.82 441.33 254.77 218.77 Other Current Assets 95.21 15.15 43.59 23.86 36.32 Short Term Loans & Adv. 81.13 22.64 18.12 15.13 8.31 Net Current Assets 870.96 1,001.27 414.19 187.08 175.32 Total Assets 4,226.46 3,754.39 2,853.58 2,418.11 2,007.62

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 2,905.63 2,428.21 1,616.01 1,382.34 1,349.54 Share Capital 53.70 53.64 50.64 82.09 81.84 Total Reserves 2,847.54 2,369.43 1,559.84 1,267.93 1,219.26 Non-Current Liabilities 719.42 1,089.49 1,586.27 1,299.73 1,008.81 Secured Loans 235.96 659.47 717.17 551.43 605.52 Unsecured Loans 47.51 77.65 50.46 26.27 0.00 Long Term Provisions 57.74 54.04 555.12 460.70 85.81 Current Liabilities 617.73 572.55 419.48 404.66 357.66 Trade Payables 186.78 194.69 134.33 131.55 130.74 Other Current Liabilities 394.48 352.09 265.84 245.40 207.99 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 36.48 25.78 19.31 27.72 18.93 Total Liabilities 4,242.75 4,090.25 3,621.76 3,086.73 2,716.01 Net Block 2,235.91 2,050.09 1,775.86 1,615.67 1,703.11 Gross Block 3,227.02 2,877.28 2,457.99 2,172.59 2,140.90 Accumulated Depreciation 991.11 827.19 682.13 556.92 437.79 Non Current Assets 2,734.02 2,510.77 2,810.03 2,584.60 2,237.41 Capital Work in Progress 387.54 326.98 439.25 463.82 381.73 Non Current Investment 0.05 0.05 0.05 0.05 0.00 Long Term Loans & Adv. 92.87 99.61 583.22 485.93 128.04 Other Non Current Assets 17.65 34.05 11.64 19.13 24.53 Current Assets 1,508.73 1,579.49 811.73 502.13 478.60 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 66.85 60.37 53.39 39.76 38.52 Sundry Debtors 215.31 194.20 180.20 133.63 149.15 Cash & Bank 1,175.28 1,278.10 511.81 289.30 250.12 Other Current Assets 51.29 18.99 46.10 23.40 40.80 Short Term Loans & Adv. 34.11 27.82 20.23 16.05 8.60 Net Current Assets 891.00 1,006.93 392.24 97.47 120.93 Total Assets 4,242.75 4,090.26 3,621.76 3,086.73 2,716.01

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 340.64 430.53 235.40 200.88 192.56 PBT 488.67 351.71 295.83 84.42 130.93 Adjustment 53.02 83.30 99.85 104.94 121.74 Changes in Working Capital -56.37 96.47 -69.49 26.16 -3.95 Cash after chg. in Working capital 485.33 531.48 326.18 215.52 248.72 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -144.69 -100.95 -90.78 -14.63 -56.16 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -698.52 -257.29 -312.99 -250.46 -45.34 Net Fixed Assets -217.62 -131.36 -58.22 -4.23 Net Investments -25.11 -30.97 -108.47 -125.05 Others -455.79 -94.96 -146.30 -121.18 Cash from Financing Activity -66.23 404.22 97.59 -36.67 -55.64 Net Cash Inflow / Outflow -424.11 577.47 20.01 -86.25 91.58 Opening Cash & Equivalents 642.78 65.31 45.31 131.55 39.98 Closing Cash & Equivalent 218.67 642.78 65.31 45.31 131.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 612.08 644.52 311.26 241.77 175.07 PBT 627.10 449.29 280.56 32.46 63.89 Adjustment 215.58 198.55 195.49 189.11 165.28 Changes in Working Capital -53.13 102.82 -66.77 36.59 2.07 Cash after chg. in Working capital 789.55 750.66 409.28 258.17 231.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -177.46 -106.14 -98.02 -16.40 -56.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -440.80 -342.35 -420.88 -239.15 -87.07 Net Fixed Assets -217.62 -131.36 -58.22 -4.23 Net Investments -25.11 -30.97 -108.47 -125.05 Others -198.07 -180.02 -254.19 -109.87 Cash from Financing Activity -513.92 345.64 159.59 -80.72 -0.88 Net Cash Inflow / Outflow -342.63 647.81 49.97 -78.11 87.12 Opening Cash & Equivalents 767.24 119.43 69.47 147.57 60.45 Closing Cash & Equivalent 424.61 767.24 119.43 69.47 147.57

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 105.94 92.61 68.49 57.23 271.92 ROA 9.04% 7.97% 8.30% 2.59% 5.46% ROE 13.55% 12.48% 13.88% 4.15% 8.00% ROCE 18.88% 17.23% 19.51% 7.69% 11.30% Fixed Asset Turnover 1.49 1.37 1.28 0.91 1.16 Receivable days 29.21 32.01 31.32 41.37 38.75 Inventory Days 6.92 7.60 7.41 9.51 6.89 Payable days 94.61 97.72 87.93 139.28 39.99 Cash Conversion Cycle -58.48 -58.10 -49.20 -88.40 5.65 Total Debt/Equity 0.02 0.04 0.07 0.02 0.02 Interest Cover 17.04 12.05 10.01 3.89 5.02

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 108.05 90.35 63.60 53.14 257.09 ROA 11.47% 8.46% 5.85% 0.99% 1.46% ROE 17.96% 16.17% 13.40% 2.23% 2.92% ROCE 21.56% 18.71% 16.38% 5.26% 6.20% Fixed Asset Turnover 1.07 1.02 0.94 0.67 0.86 Receivable days 22.82 25.21 26.43 35.67 38.11 Inventory Days 7.09 7.66 7.84 9.87 7.52 Payable days 93.08 97.60 91.04 139.29 40.14 Cash Conversion Cycle -63.17 -64.72 -56.77 -93.75 5.49 Total Debt/Equity 0.14 0.35 0.52 0.48 0.48 Interest Cover 8.48 6.20 4.25 1.45 2.13

Top Investors:

dunearn investments (mauritius) pte ltd

sunil sachdeva

rj corp limited

government pension fund global

kotak emerging equity scheme

polaris healthcare investments pte ltd

invesco india midcap fund

canara robeco mutual fund a/c canara robeco emergi

novo holdings a/s

Annual Reports:

News Update:

Global Health gets nod to sign agreement to operate 750 bedded hospital in New Delhi
6th Nov 2024, 16:13 PM

Medanta is expected to incur a project capex of upto around Rs 600 crore in next 3-4 years
Read More

Global Health Ltd.

Hospital & Healthcare Services

BSE: 543654 | NSE: MEDANTA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Global Health Ltd.

Hospital & Healthcare Services

BSE: 543654 | NSE: MEDANTA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: